We are live on
!
Find out more
JF
Jump Financial Portfolio holdings
AUM
$7.5B
1-Year Est. Return
33.9%
This Fund
S&P 500
This Quarter
Est. Return
+5.93%
1 Year Est. Return
+33.9%
3 Year Est. Return
+69.87%
5 Year Est. Return
+55.07%
10 Year Est. Return
–
AUM
$2.71B
AUM Growth
+$256M
(+10%)
Cap. Flow
+$184M
Cap. Flow
% of AUM
6.78%
Top 10 Holdings %
Top 10 Hldgs %
6.67%
Holding
2,298
New
784
Increased
473
Reduced
488
Closed
552
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$19.5M |
| 2 |
Target
TGT
|
+$17.3M |
| 3 |
Royalty Pharma
RPRX
|
+$15.5M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$14.9M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$14.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$12.2M |
| 2 |
ProShares Short VIX Short-Term Futures ETF
SVXY
|
+$11M |
| 3 |
iShares Semiconductor ETF
SOXX
|
+$10.4M |
| 4 |
ProShares UltraPro Short QQQ
SQQQ
|
+$8.83M |
| 5 |
ProShares UltraPro S&P 500
UPRO
|
+$8.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.61% |
| 2 | Industrials | 13.75% |
| 3 | Healthcare | 12.7% |
| 4 | Consumer Discretionary | 12.54% |
| 5 | Financials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLI
1701
Standard Lithium
SLI
$507M
| $69.3K | ﹤0.01% |
+15,400
| New | +$59.9K |
|
|
BKCC
1702
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $69.2K | ﹤0.01% |
21,100
+5,036
| +31% | +$16.5K |
|
1703
Puma Biotechnology
PBYI
$386M
| $68.8K | ﹤0.01% |
19,500
-15,400
| -44% | -$48K |
|
|
ORGN
1704
DELISTED
Origin Materials
ORGN
| $68.2K | ﹤0.01% |
+533
| New | +$68.6K |
|
1705
MannKind Corp
MNKD
$1.19B
| $68K | ﹤0.01% |
16,720
-37,918
| -69% | -$158K |
|
|
AUGX
1706
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $65.9K | ﹤0.01% |
+13,700
| New | +$47.4K |
|
1707
KNOT Offshore Partners
KNOP
$370M
| $65.7K | ﹤0.01% |
13,300
-24,500
| -65% | -$122K |
|
|
YALA
1708
Yalla Group
YALA
$837M
| $64.6K | ﹤0.01% |
+14,810
| New | +$59.2K |
|
|
VNET
1709
VNET Group
VNET
$2.03B
| $64.2K | ﹤0.01% |
+22,135
| New | +$67.3K |
|
|
TVRD
1710
Tvardi Therapeutics
TVRD
$19M
| $64K | ﹤0.01% |
+628
| New | +$86.5K |
|
1711
Hydrofarm Holdings
HYFM
$9.82M
| $63K | ﹤0.01% |
+8,050
| New | +$96.2K |
|
1712
ImmunityBio
IBRX
$7.55B
| $62.9K | ﹤0.01% |
+22,635
| New | +$64K |
|
1713
Alignment Healthcare
ALHC
$3.02B
| $61.4K | ﹤0.01% |
10,670
-1,641
| -13% | -$10.6K |
|
1714
Planet Labs
PL
$7.65B
| $60.1K | ﹤0.01% |
+18,663
| New | +$74K |
|
1715
Butterfly Network
BFLY
$2.18B
| $59.9K | ﹤0.01% |
+26,061
| New | +$58.2K |
|
1716
MDxHealth
MDXH
$23.1M
| $59K | ﹤0.01% |
+17,300
| New | +$63.3K |
|
|
KEEL
1717
Keel Infrastructure Corp
KEEL
$2.54B
| $58.2K | ﹤0.01% |
+39,625
| New | +$46K |
|
|
BHR
1718
Braemar Hotels & Resorts
BHR
$152M
| $57.9K | ﹤0.01% |
+14,400
| New | +$56.8K |
|
1719
Vor Biopharma
VOR
$1.15B
| $57.5K | ﹤0.01% |
930
+414
| +80% | +$37.8K |
|
|
ASRT
1720
DELISTED
Assertio
ASRT
| $56.1K | ﹤0.01% |
+690
| New | +$64.1K |
|
1721
Compass
COMP
$8.68B
| $55.3K | ﹤0.01% |
+15,804
| New | +$51.8K |
|
1722
Quad
QUAD
$572M
| $53.2K | ﹤0.01% |
14,142
-13,041
| -48% | -$47.1K |
|
1723
Baytex Energy
BTE
$3.13B
| $51.5K | ﹤0.01% |
+15,786
| New | +$55.3K |
|
1724
C4 Therapeutics
CCCC
$385M
| $49.3K | ﹤0.01% |
+17,915
| New | +$57.6K |
|
1725
Alto Ingredients
ALTO
$374M
| $48K | ﹤0.01% |
+16,601
| New | +$31.6K |
|
Similar funds
YAM
ASN
SP
AMH
BIM
CCM
GJL
DKCM
Jump Financial's Q2 2023 Portfolio in Review
As of Q2 2023, Jump Financial held 2,298 positions worth $2.71B, up 10% from $2.46B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Jump Financial deployed $184M of net new capital in Q2 2023, opening 784 new positions and adding to 473 existing holdings. Its largest new stake was Royalty Pharma: 456,285 shares worth $14M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $12.2M trimmed.
- Jump Financial's largest Q2 2023 buy was Royalty Pharma: 456,285 shares worth $14M.
- Jump Financial added most to State Street Utilities Select Sector SPDR ETF in Q2 2023, an estimated $19.5M increase.
- Jump Financial's biggest Q2 2023 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $12.2M.
- Jump Financial fully exited ProShares Short VIX Short-Term Futures ETF in Q2 2023, selling an estimated $11M.
- Jump Financial's ten largest holdings make up 6.7% of its $2.71B portfolio in Q2 2023.
- Jump Financial opened 784 new positions and closed 552 in Q2 2023.
- Jump Financial's portfolio value rose 10% quarter-over-quarter to $2.71B.
Based on Jump Financial's 13F filing for Q2 2023, filed 7 Aug 2023.